Share Name Share Symbol Market Type Share ISIN Share Description
Immunodiagnostic Systems Hldgs LSE:IDH London Ordinary Share GB00B01YZ052 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.00p -1.44% 208.00p 200.00p 216.00p 208.00p 208.00p 208.00p 0 08:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 37.9 0.9 4.2 49.5 59.87

Immunodiagnostic Systems Hldgs PLC Transaction in Own Shares

07/08/2018 7:00am

UK Regulatory (RNS & others)

Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart

6 Months : From May 2018 to Nov 2018

Click Here for more Immunodiagnostic Systems Charts.


RNS Number : 9870W

Immunodiagnostic Systems Hldgs PLC

07 August 2018

Immunodiagnostic Systems Holdings plc

Transaction in Own Shares

06 August 2018

Immunodiagnostic Systems Holdings plc (IDH.L) ("IDS" or the "Company"), a specialist producer of manual and automated diagnostic testing kits and instrumentation for the clinical and research markets, announces that it has purchased (through Peel Hunt LLP acting as the Company's broker) the following number of its shares of 2p each on the London Stock Exchange. The purchased shares will be held as treasury shares.

The purchases were made pursuant to the buy-back programme announced on 21 June 2017.

 Date of purchase:                                  06 August 2018 
 Number of shares purchased (aggregated volume):    201 
 Highest price paid per share (pence):              240 
 Lowest price paid per share (pence):               240 
 Volume weighted average price paid per share 
  (pence):                                          240 

Following the purchase of these shares, IDS holds 65,852 ordinary shares as treasury shares and the Company's issued share capital (excluding shares held as treasury shares) consists of 29,384,323 shares. All of the shares have equal voting rights. This figure 29,384,323 represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), detailed information about the individual purchases made by Peel Hunt on the Company's behalf is set out in the schedule below.

For further information:

 Immunodiagnostic Systems Holdings     Tel : +44 (0)191 519 0660 
 Paul Martin, Group Finance Director 
 Peel Hunt LLP                         Tel : +44 (0)207 418 8900 
 James Steel 
 Oliver Jackson 

Schedule of Purchases - Individual Transactions

 Number of shares purchased   Transaction price    Time of transaction   Trading venue 
                               (pence per share) 
 201                          240                  16:25:35              London Stock Exchange 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit



(END) Dow Jones Newswires

August 07, 2018 02:00 ET (06:00 GMT)

1 Year Immunodiagnostic Systems Chart

1 Year Immunodiagnostic Systems Chart

1 Month Immunodiagnostic Systems Chart

1 Month Immunodiagnostic Systems Chart
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V:gb D:20181119 16:23:07